InsidersTradesSigma
Track the 팬젠 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 팬젠 has recorded 4 public disclosures. Market capitalisation: €67bn. The latest transaction was reported on 24 April 2026 (Sale). Among the most active insiders: 오한규. The full history is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
4 ops.
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,477 of 29,063 companies
52.1
score / 100
Value38
Quality66
FCF yld-0.8%
Earn yld3.0%
EV/EBITDA18.6x
ROE7.3%
Gross mgn34%
Net mgn15%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 April 2026
关于 팬젠
팬젠是一家在XKRX市场上市的健康和制药公司。它专注于生物制药解决方案的开发。